. Author manuscript; available in PMC: 2015 Mar 1.

Published in final edited form as: Immunol Rev. 2014 Mar;258(1):12–29. doi: 10.1111/imr.12138

Table 1.

Emerging viral pathogens implicated in complications after HSCT

Virus	Incidence After Allogeneic HSCT
HHV6	33–48%(120–125)
HHV7	10–57%(126, 127)
Parvovirus	Up to 30%(128–131)
BK virus	10–25%(132–136)
Coronavirus	8.8%(137–139)
Parainfluenza	4–7%(140–144)
Influenza	1.3–2.6%(144, 145)
RSV	1.8–6%(141, 144, 146)
Metapneumovirus	5%(147, 148)
Bocavirus	5%(149, 150)
KI virus/WU virus	1–8%(149–152)
JC virus	~1%(153, 154)